We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+23.56%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$135M
AUM Growth
+$62.2M
Cap. Flow
+$48.4M
Cap. Flow %
35.91%
Top 10 Hldgs %
44.79%
Holding
162
New
9
Increased
113
Reduced
25
Closed
15

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$4.79M
2
EEP
Enbridge Energy Partners
EEP
+$3.1M
3
PAA icon
Plains All American Pipeline
PAA
+$2.86M
4
WPZ
Williams Partners L.P.
WPZ
+$2.84M
5
ETP
Energy Transfer Partners, L.P.
ETP
+$2.77M

Top Sells

Rank Stock Value
1
TRGP icon
Targa Resources
TRGP
+$572K
2
XNPT
XENOPORT, INC.
XNPT
+$458K
3
MDVN
MEDIVATION, INC.
MDVN
+$291K
4
TBPH icon
Theravance Biopharma
TBPH
+$289K
5
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$275K

Sector Composition

Rank Sector Weight
1 Energy 64.17%
2 Healthcare 25.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WES icon
26
Western Midstream Partners
WES
$19.4B
$788K 0.58%
20,602
+5,291
+35% +$209K
KERX
27
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$613K 0.45%
92,536
-43,936
-32% -$246K
SE
28
DELISTED
Spectra Energy Corp Wi
SE
$597K 0.44%
16,311
+7,830
+92% +$250K
TVTX icon
29
Travere Therapeutics
TVTX
$5.23B
$585K 0.43%
32,857
+4,223
+15% +$68.4K
EXEL icon
30
Exelixis
EXEL
$13.8B
$580K 0.43%
74,230
-40,199
-35% -$232K
IONS icon
31
Ionis Pharmaceuticals
IONS
$8.93B
$567K 0.42%
24,345
+13,898
+133% +$448K
SGEN
32
DELISTED
Seagen Inc. Common Stock
SGEN
$565K 0.42%
13,991
-550
-4% -$20.9K
VNDA icon
33
Vanda Pharmaceuticals
VNDA
$322M
$563K 0.42%
50,287
-16,734
-25% -$162K
LGND icon
34
Ligand Pharmaceuticals
LGND
$6.1B
$561K 0.42%
7,542
-1,343
-15% -$99.7K
IRWD icon
35
Ironwood Pharmaceuticals
IRWD
$639M
$553K 0.41%
50,479
-13,744
-21% -$134K
TBPH icon
36
Theravance Biopharma
TBPH
$871M
$552K 0.41%
24,323
-13,380
-35% -$289K
ICPT
37
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$546K 0.41%
3,826
+2,291
+149% +$334K
PDLI
38
DELISTED
PDL BioPharma, Inc.
PDLI
$546K 0.41%
173,837
+15,203
+10% +$50.7K
MDVN
39
DELISTED
MEDIVATION, INC.
MDVN
$546K 0.41%
9,058
-5,139
-36% -$291K
INCY icon
40
Incyte
INCY
$23.1B
$545K 0.4%
6,820
+1,707
+33% +$133K
BIIB icon
41
Biogen
BIIB
$29.2B
$544K 0.4%
2,251
+206
+10% +$54.3K
GILD icon
42
Gilead Sciences
GILD
$162B
$543K 0.4%
6,511
+701
+12% +$62.2K
AMGN icon
43
Amgen
AMGN
$198B
$541K 0.4%
3,557
-87
-2% -$13.5K
ACOR
44
DELISTED
Acorda Therapeutics
ACOR
$539K 0.4%
176
+48
+38% +$156K
UTHR icon
45
United Therapeutics
UTHR
$26.2B
$537K 0.4%
5,073
+1,404
+38% +$157K
RPTP
46
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$535K 0.4%
99,654
-27,215
-21% -$140K
CELG
47
DELISTED
Celgene Corp
CELG
$531K 0.39%
5,386
+502
+10% +$51.9K
HALO icon
48
Halozyme
HALO
$9.23B
$529K 0.39%
61,274
+24,579
+67% +$243K
ENLC
49
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$528K 0.39%
33,190
+15,939
+92% +$227K
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$11.3B
$522K 0.39%
6,713
+811
+14% +$68.9K
1
2
3 4 5

Similar funds

EFS
Econ Financial Services Harrisburg, Pennsylvania $215M AUM 6.73% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return

Virtus ETF Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, Virtus ETF Advisers held 162 positions worth $135M, up 86% from $72.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Virtus ETF Advisers deployed $48.4M of net new capital in Q2 2016, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Cheniere Energy: 11,685 shares worth $350K.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 49% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Targa Resources, an estimated $572K trimmed.

  • Virtus ETF Advisers's largest Q2 2016 buy was Cheniere Energy: 11,685 shares worth $350K.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q2 2016, an estimated $4.79M increase.
  • Virtus ETF Advisers's biggest Q2 2016 reduction was Targa Resources, cutting an estimated $572K.
  • Virtus ETF Advisers fully exited XENOPORT, INC. in Q2 2016, selling an estimated $458K.
  • Virtus ETF Advisers's ten largest holdings make up 45% of its $135M portfolio in Q2 2016.
  • Virtus ETF Advisers opened 9 new positions and closed 15 in Q2 2016.
  • Virtus ETF Advisers's portfolio value rose 86% quarter-over-quarter to $135M.

Based on Virtus ETF Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.